Financial Snapshot
Revenues
Revenues
Revenue YoY Change
Revenues
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $27.12B | $27.28B | $27.31B | $24.69B | $22.45B | $22.13B | $26.11B | $30.39B | $32.64B | $24.89B | $11.20B | $9.703B | $8.385B | $7.949B | $7.011B | $5.336B | $4.230B | $3.026B | $2.028B | $1.325B | $868.0M | $467.0M | $234.0M | $196.0M | $169.0M | $151.0M | $132.0M | $33.00M | $3.000M | $5.000M | $4.000M | $4.000M | $3.000M | $1.000M |
YoY Change | -0.6% | -0.09% | 10.6% | 9.98% | 1.46% | -15.24% | -14.09% | -6.89% | 31.13% | 122.19% | 15.45% | 15.71% | 5.48% | 13.38% | 31.39% | 26.15% | 39.79% | 49.21% | 53.06% | 52.65% | 85.87% | 99.57% | 19.39% | 15.98% | 11.92% | 14.39% | 300.0% | 1000.0% | -40.0% | 25.0% | 0.0% | 33.33% | 200.0% |
Expenses
Cost Of Revenues
Gross Profit
Gross Profit Margin
Gross Profit
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $27.12B | $27.28B | $27.31B | $24.69B | $22.45B | $22.13B | $26.11B | $30.39B | $32.64B | $24.89B | $11.20B | $9.703B | $8.385B | $7.949B | $7.011B | $5.336B | $4.230B | $3.026B | $2.028B | $1.325B | $868.0M | $467.0M | $234.0M | $196.0M | $169.0M | $151.0M | $132.0M | $33.00M | $3.000M | $5.000M | $4.000M | $4.000M | $3.000M | $1.000M |
Cost Of Revenue | $6.019B | $5.615B | $6.601B | $4.572B | $4.675B | $4.853B | $4.371B | $4.261B | $4.006B | $3.788B | $2.859B | $2.471B | $2.124B | $1.870B | $1.596B | $1.127B | $769.0M | $433.0M | $260.0M | $167.0M | $113.0M | $70.00M | $44.00M | $34.00M | $30.00M | $23.00M | $22.00M | $1.000M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Gross Profit | $21.10B | $21.67B | $20.70B | $20.12B | $17.77B | $17.27B | $21.74B | $26.13B | $28.63B | $21.10B | $8.343B | $7.232B | $6.261B | $6.080B | $5.416B | $4.209B | $3.461B | $2.593B | $1.768B | $1.158B | $755.0M | $397.0M | $190.0M | $162.0M | $139.0M | $128.0M | $111.0M | $33.00M | $3.000M | $5.000M | $4.000M | $4.000M | $3.000M | $1.000M |
Gross Profit Margin | 77.8% | 79.42% | 75.82% | 81.48% | 79.18% | 78.07% | 83.26% | 85.98% | 87.73% | 84.78% | 74.48% | 74.53% | 74.67% | 76.48% | 77.25% | 78.88% | 81.82% | 85.69% | 87.18% | 87.4% | 86.98% | 85.01% | 81.2% | 82.65% | 82.25% | 84.77% | 84.09% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Selling, General & Admin Expense
Research & Development
Depreciation, Depletion & Amortization
SGA Expense to Gross Profit Ratio
R&D To Gross Profit Ratio
DDA To Gross Profit Ratio
Operating Expenses Total
Operating Profits/Loss
Operational Expenses
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General & Admin | $6.090B | $5.673B | $5.246B | $5.151B | $4.381B | $4.056B | $3.878B | $3.398B | $3.426B | $2.983B | $1.699B | $1.461B | $1.242B | $1.044B | $912.0M | $797.0M | $706.0M | $574.0M | $379.0M | $307.0M | $233.0M | $174.0M | $125.0M | $82.00M | $99.00M | $82.00M | $71.00M | $27.00M | $9.000M | $10.00M | $8.000M | $4.000M | $2.000M | $1.000M |
YoY Change | 7.35% | 8.14% | 1.84% | 17.58% | 8.01% | 4.59% | 14.13% | -0.82% | 14.85% | 75.57% | 16.29% | 17.63% | 18.92% | 14.52% | 14.43% | 12.89% | 23.0% | 51.45% | 23.45% | 31.76% | 33.91% | 39.2% | 52.44% | -17.17% | 20.73% | 15.49% | 162.96% | 200.0% | -10.0% | 25.0% | 100.0% | 100.0% | 100.0% | |
% of Gross Profit | 28.87% | 26.18% | 25.34% | 25.61% | 24.65% | 23.48% | 17.84% | 13.0% | 11.97% | 14.14% | 20.36% | 20.2% | 19.84% | 17.18% | 16.84% | 18.94% | 20.4% | 22.14% | 21.44% | 26.51% | 30.86% | 43.83% | 65.79% | 50.62% | 71.22% | 64.06% | 63.96% | 81.82% | 300.0% | 200.0% | 200.0% | 100.0% | 66.67% | 100.0% |
Research & Development | $6.875B | $5.912B | $5.363B | $5.039B | $9.106B | $5.018B | $3.734B | $5.098B | $3.014B | $2.854B | $2.120B | $1.760B | $1.229B | $1.073B | $914.0M | $722.0M | $591.0M | $384.0M | $278.0M | $224.0M | $182.0M | $142.0M | $186.0M | $132.0M | $111.0M | $125.0M | $112.0M | $42.00M | $26.00M | $30.00M | $26.00M | $18.00M | $7.000M | $5.000M |
YoY Change | 16.29% | 10.24% | 6.43% | -44.66% | 81.47% | 34.39% | -26.76% | 69.14% | 5.61% | 34.62% | 20.45% | 43.19% | 14.56% | 17.39% | 26.59% | 22.17% | 53.91% | 38.13% | 24.11% | 23.08% | 28.17% | -23.66% | 40.91% | 18.92% | -11.2% | 11.61% | 166.67% | 61.54% | -13.33% | 15.38% | 44.44% | 157.14% | 40.0% | |
% of Gross Profit | 32.59% | 27.29% | 25.9% | 25.05% | 51.23% | 29.05% | 17.18% | 19.51% | 10.53% | 13.52% | 25.41% | 24.34% | 19.63% | 17.65% | 16.88% | 17.15% | 17.08% | 14.81% | 15.72% | 19.34% | 24.11% | 35.77% | 97.89% | 81.48% | 79.86% | 97.66% | 100.9% | 127.27% | 866.67% | 600.0% | 650.0% | 450.0% | 233.33% | 500.0% |
Depreciation & Amortization | $354.0M | $323.0M | $329.0M | $288.0M | $255.0M | $226.0M | $233.0M | $177.0M | $161.0M | $125.0M | $103.0M | $83.00M | $72.19M | $67.24M | $213.0M | $156.0M | $101.0M | $48.00M | $35.00M | $24.00M | $21.00M | $14.00M | $15.00M | $12.00M | $13.00M | $13.00M | $15.00M | $4.000M | $3.000M | $4.000M | $3.000M | $2.000M | $1.000M | $1.000M |
YoY Change | 9.6% | -1.82% | 14.24% | 12.94% | 12.83% | -3.0% | 31.64% | 9.94% | 28.8% | 21.36% | 24.1% | 14.98% | 7.36% | -68.43% | 36.54% | 54.46% | 110.42% | 37.14% | 45.83% | 14.29% | 50.0% | -6.67% | 25.0% | -7.69% | 0.0% | -13.33% | 275.0% | 33.33% | -25.0% | 33.33% | 50.0% | 100.0% | 0.0% | |
% of Gross Profit | 1.68% | 1.49% | 1.59% | 1.43% | 1.43% | 1.31% | 1.07% | 0.68% | 0.56% | 0.59% | 1.23% | 1.15% | 1.15% | 1.11% | 3.93% | 3.71% | 2.92% | 1.85% | 1.98% | 2.07% | 2.78% | 3.53% | 7.89% | 7.41% | 9.35% | 10.16% | 13.51% | 12.12% | 100.0% | 80.0% | 75.0% | 50.0% | 33.33% | 100.0% |
Operating Expenses | $12.97B | $11.59B | $10.61B | $10.19B | $13.49B | $9.074B | $7.612B | $8.496B | $6.440B | $5.837B | $3.819B | $3.221B | $2.471B | $2.117B | $1.826B | $1.519B | $1.297B | $958.0M | $657.0M | $530.0M | $415.0M | $316.0M | $310.0M | $214.0M | $210.0M | $208.0M | $182.0M | $68.00M | $35.00M | $40.00M | $34.00M | $22.00M | $9.000M | $6.000M |
YoY Change | 11.91% | 9.2% | 4.11% | -24.45% | 48.63% | 19.21% | -10.4% | 31.93% | 10.33% | 52.84% | 18.57% | 30.35% | 16.71% | 15.95% | 20.21% | 17.12% | 35.39% | 45.81% | 23.96% | 27.71% | 31.33% | 1.94% | 44.86% | 1.9% | 0.96% | 14.29% | 167.65% | 94.29% | -12.5% | 17.65% | 54.55% | 144.44% | 50.0% | |
Operating Profit | $8.132B | $10.08B | $9.918B | $4.071B | $4.287B | $8.200B | $14.12B | $17.63B | $22.19B | $15.27B | $4.524B | $4.010B | $3.790B | $3.962B | $3.590B | $2.690B | $2.164B | $1.635B | $1.111B | $628.0M | $340.0M | $81.00M | -$120.0M | -$52.00M | -$71.00M | -$80.00M | -$71.00M | -$35.00M | -$32.00M | -$35.00M | -$30.00M | -$18.00M | -$6.000M | -$5.000M |
YoY Change | -19.33% | 1.64% | 143.63% | -5.04% | -47.72% | -41.94% | -19.9% | -20.55% | 45.38% | 237.42% | 12.82% | 5.81% | -4.35% | 10.37% | 33.46% | 24.31% | 32.35% | 47.16% | 76.91% | 84.71% | 319.75% | -167.5% | 130.77% | -26.76% | -11.25% | 12.68% | 102.86% | 9.38% | -8.57% | 16.67% | 66.67% | 200.0% | 20.0% |
Interest Expenses
Interest Expenses To Operating Income %
Other Expense/Income
Interest & Other Expense/Income
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Interest Expense | -$944.0M | -$935.0M | $1.001B | $984.0M | $995.0M | $1.077B | $1.118B | $964.0M | $688.0M | $412.0M | $307.0M | $361.0M | $205.4M | $109.0M | -$70.00M | -$65.00M | -$63.00M | -$14.00M | $4.000M | $6.000M | -$22.00M | -$30.00M | -$5.000M | -$4.000M | -$7.000M | -$7.000M | -$5.000M | -$1.000M | -$1.000M | -$1.000M | $0.00 | $0.00 | $0.00 | $0.00 |
YoY Change | 0.96% | -193.41% | 1.73% | -1.11% | -7.61% | -3.67% | 15.98% | 40.12% | 66.99% | 34.2% | -14.96% | 75.74% | 88.52% | -255.66% | 7.69% | 3.17% | 350.0% | -450.0% | -33.33% | -127.27% | -26.67% | 500.0% | 25.0% | -42.86% | 0.0% | 40.0% | 400.0% | 0.0% | 0.0% | |||||
% of Operating Profit | -11.61% | -9.27% | 10.09% | 24.17% | 23.21% | 13.13% | 7.92% | 5.47% | 3.1% | 2.7% | 6.79% | 9.0% | 5.42% | 2.75% | -1.95% | -2.42% | -2.91% | -0.86% | 0.36% | 0.96% | -6.47% | -37.04% | ||||||||||||
Other Income/Expense, Net | $198.0M | -$581.0M | -$639.0M | -$1.418B | $1.868B | $676.0M | $523.0M | $428.0M | $154.0M | $3.000M | -$9.000M | -$37.00M | $66.58M | $60.29M | $42.00M | $59.00M | $110.0M | $135.0M | $47.00M | $23.00M | $13.00M | $22.00M | $26.00M | $18.00M | $16.00M | $22.00M | $21.00M | $15.00M | $5.000M | $5.000M | $4.000M | $4.000M | $2.000M | $1.000M |
YoY Change | -134.08% | -9.08% | -54.94% | -175.91% | 176.33% | 29.25% | 22.2% | 177.92% | 5033.33% | -133.33% | -75.68% | -155.57% | 10.44% | 43.54% | -28.81% | -46.36% | -18.52% | 187.23% | 104.35% | 76.92% | -40.91% | -15.38% | 44.44% | 12.5% | -27.27% | 4.76% | 40.0% | 200.0% | 0.0% | 25.0% | 0.0% | 100.0% | 100.0% |
Income/Loss
Pretax Income
Income Tax
Net Profits/Loss
Pretax Income YoY Change
Income Tax Rate
Net Profits/Loss YoY Change
Basic EPS
Net Income To Revenue Ratio
Pretax & Net Income
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pretax Income | $6.859B | $5.814B | $8.278B | $1.669B | $5.160B | $7.074B | $8.099B | $7.646B | $7.953B | $6.678B | $3.470B | $3.612B | $3.651B | $3.914B | $3.502B | $2.673B | $2.211B | -$638.0M | $1.162B | $656.0M | -$168.0M | $73.00M | $57.00M | -$39.00M | -$61.00M | -$43.00M | -$73.00M | -$22.00M | -$27.00M | -$31.00M | -$26.00M | -$14.00M | -$5.000M | -$4.000M |
YoY Change | 17.97% | -29.77% | 395.99% | -67.66% | -27.06% | -12.66% | 5.92% | -3.86% | 19.09% | 92.45% | -3.93% | -1.07% | -6.71% | 11.75% | 31.01% | 20.9% | -446.55% | -154.91% | 77.13% | -490.48% | -330.14% | 28.07% | -246.15% | -36.07% | 41.86% | -41.1% | 231.82% | -18.52% | -12.9% | 19.23% | 85.71% | 180.0% | 25.0% | |
Income Tax | $1.247B | $1.248B | $2.077B | $1.580B | -$204.0M | $2.339B | $8.885B | $3.609B | $3.553B | $2.797B | $1.151B | $1.038B | $861.9M | $1.024B | $876.0M | $702.0M | $635.0M | $552.0M | $348.0M | $207.0M | -$96.00M | $1.000M | $4.000M | $1.000M | $1.000M | $1.000M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | 18.18% | 21.47% | 25.09% | 94.67% | -3.95% | 33.06% | 109.7% | 47.2% | 44.67% | 41.88% | 33.17% | 28.74% | 23.61% | 26.16% | 25.01% | 26.26% | 28.72% | 29.95% | 31.55% | 1.37% | 7.02% | |||||||||||||
Net Earnings | $5.665B | $4.592B | $6.225B | $123.0M | $5.386B | $5.455B | $4.628B | $13.50B | $18.11B | $12.10B | $3.075B | $2.592B | $2.804B | $2.901B | $2.636B | $1.979B | $1.585B | -$1.190B | $814.0M | $449.0M | -$72.00M | $72.00M | $52.00M | -$57.00M | -$66.00M | -$45.00M | -$73.00M | -$22.00M | -$27.00M | -$31.00M | -$26.00M | -$14.00M | -$5.000M | -$4.000M |
YoY Change | 23.37% | -26.23% | 4960.98% | -97.72% | -1.26% | 17.87% | -65.72% | -25.44% | 49.64% | 293.53% | 18.63% | -7.55% | -3.36% | 10.06% | 33.2% | 24.86% | -233.19% | -246.19% | 81.29% | -723.61% | -200.0% | 38.46% | -191.23% | -13.64% | 46.67% | -38.36% | 231.82% | -18.52% | -12.9% | 19.23% | 85.71% | 180.0% | 25.0% | |
Net Earnings / Revenue | 20.89% | 16.83% | 22.8% | 0.5% | 23.99% | 24.65% | 17.73% | 44.43% | 55.48% | 48.62% | 27.45% | 26.71% | 33.43% | 36.5% | 37.6% | 37.09% | 37.47% | -39.33% | 40.14% | 33.89% | -8.29% | 15.42% | 22.22% | -29.08% | -39.05% | -29.8% | -55.3% | -66.67% | -900.0% | -620.0% | -650.0% | -350.0% | -166.67% | -400.0% |
Basic Earnings Per Share | $4.54 | $3.66 | $4.96 | $0.10 | $4.24 | $4.20 | $3.54 | $10.08 | $12.37 | $7.95 | $2.01 | $1.71 | $1.81 | $1.69 | ||||||||||||||||||||
Diluted Earnings Per Share | $4.50 | $3.639M | $4.93 | $0.10 | $4.22 | $4.17 | $3.51 | $9.94 | $11.91 | $7.35 | $1.81 | $1.64 | $1.77 | $1.66 | $1.411M | $1.032M | $821.7K | -$648.1K | $429.1K | $241.8K | -$44.75K | $43.58K | $32.12K | -$39.12K | -$48.18K | -$34.30K | -$57.84K | -$24.75K | -$39.65K | -$51.07K | -$43.26K | -$27.24K | -$13.97K | -$12.54K |
Assets & Liabilities
Cash & Short-Term Investments
Cash & Equivalents
Cash To Operating Expenses Ratio
Inventory
Receivables
Total Short-Term Assets
Property, Plant And Equipment
Long-Term Investments
Total Long-Term Assets
Total Assets
Net Income To Total Assets Percentage
Accounts Payable
Short-Term Debt
Long Term Debt Due
Total Short-Term Liabilities
Long-Term Debt
Other Long-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
Short-Term To Long-Term Debt Ratio
Short-Term Assets To Debt Ratio
Long-Term Debt To Net Income Ratio
Assets & Liabilities
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Short-Term Investments | $8.428B | $7.630B | $6.520B | $7.408B | $24.35B | $30.09B | $25.51B | $11.90B | $14.61B | $10.13B | $2.132B | $1.862B | $9.900B | $2.099B | $1.657B | $1.790B | $1.172B | $937.0M | $2.311B | $1.254B | $707.0M | $942.0M | $583.0M | $513.0M | $294.0M | $349.0M | $322.0M | $296.0M | $156.0M | $89.00M | $115.0M | $139.0M | $105.0M | |
YoY Change | 10.46% | 17.02% | -11.99% | -69.58% | -19.07% | 17.95% | 114.46% | -18.57% | 44.23% | 375.05% | 14.5% | -81.19% | 371.65% | 26.67% | -7.43% | 52.73% | 25.08% | -59.45% | 84.29% | 77.37% | -24.95% | 61.58% | 13.65% | 74.49% | -15.76% | 8.39% | 8.78% | 89.74% | 75.28% | -22.61% | -17.27% | 32.38% | ||
Cash & Equivalents | $8.428B | $7.630B | $5.338B | $5.997B | $11.63B | $17.94B | $7.588B | $8.229B | $12.85B | $10.03B | $2.113B | $1.804B | $9.884B | $908.0M | $1.273B | $1.459B | $968.0M | $816.0M | $708.0M | $281.0M | $195.0M | $617.0M | $123.0M | $197.0M | $47.00M | $101.0M | $32.00M | $132.0M | $27.00M | $30.00M | $13.00M | $2.000M | $88.00M | |
Short-Term Investments | $1.179B | $973.0M | $1.182B | $1.411B | $12.72B | $12.15B | $17.92B | $3.666B | $1.757B | $101.0M | $19.00M | $59.00M | $16.00M | $1.191B | $384.0M | $331.0M | $204.0M | $121.0M | $1.603B | $973.0M | $512.0M | $325.0M | $459.0M | $316.0M | $247.0M | $248.0M | $290.0M | $164.0M | $128.0M | $59.00M | $102.0M | $137.0M | $17.00M | |
Other Short-Term Assets | $2.374B | $1.774B | $2.141B | $2.013B | $1.440B | $1.606B | $1.661B | $1.592B | $2.345B | $1.565B | $986.0M | $798.0M | $677.0M | $784.0M | $714.0M | $537.0M | $461.0M | $319.0M | $168.0M | $88.00M | $226.0M | $15.00M | $11.00M | $12.00M | $11.00M | $9.000M | $18.00M | $4.000M | $2.000M | $2.000M | $2.000M | $1.000M | $1.000M | |
YoY Change | 33.82% | -17.14% | 6.36% | 39.79% | -10.34% | -3.31% | 4.33% | -32.11% | 49.84% | 58.72% | 23.56% | 17.87% | -13.65% | 9.8% | 32.96% | 16.49% | 44.51% | 89.88% | 90.91% | -61.06% | 1406.67% | 36.36% | -8.33% | 9.09% | 22.22% | -50.0% | 350.0% | 100.0% | 0.0% | 0.0% | 100.0% | 0.0% | ||
Inventory | $3.366B | $2.820B | $1.618B | $1.683B | $922.0M | $814.0M | $801.0M | $1.587B | $1.955B | $1.386B | $1.697B | $1.745B | $1.390B | $1.204B | $1.052B | $928.0M | $600.0M | $564.0M | $217.0M | $136.0M | $98.00M | $52.00M | $39.00M | $21.00M | $21.00M | $17.00M | ||||||||
Prepaid Expenses | ||||||||||||||||||||||||||||||||||
Receivables | $4.660B | $4.777B | $4.493B | $4.892B | $3.582B | $3.327B | $3.851B | $4.514B | $5.854B | $4.635B | $2.182B | $1.751B | $1.951B | $1.622B | $1.390B | $1.023B | $795.0M | $609.0M | $396.0M | $371.0M | $235.0M | $125.0M | $74.00M | $49.00M | $46.00M | $43.00M | ||||||||
Other Receivables | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $50.00M | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
Total Short-Term Assets | $16.45B | $15.23B | $14.77B | $16.00B | $30.30B | $35.84B | $31.82B | $19.59B | $24.76B | $17.71B | $6.997B | $6.156B | $13.92B | $5.708B | $4.813B | $4.278B | $3.028B | $2.429B | $3.092B | $1.850B | $1.266B | $1.184B | $708.0M | $594.0M | $372.0M | $417.0M | $340.0M | $300.0M | $157.0M | $91.00M | $117.0M | $140.0M | $106.0M | |
YoY Change | 8.06% | 3.08% | -7.65% | -47.2% | -15.46% | 12.61% | 62.46% | -20.89% | 39.79% | 153.17% | 13.66% | -55.77% | 143.85% | 18.6% | 12.51% | 41.28% | 24.66% | -21.44% | 67.14% | 46.13% | 6.93% | 67.23% | 19.19% | 59.68% | -10.79% | 22.65% | 13.33% | 91.08% | 72.53% | -22.22% | -16.43% | 32.08% | ||
Property, Plant & Equipment | $5.317B | $5.475B | $5.663B | $5.613B | $5.170B | $4.006B | $3.295B | $2.865B | $2.276B | $1.674B | $1.166B | $1.100B | $774.0M | $701.0M | $700.0M | $529.0M | $448.0M | $361.0M | $243.0M | $223.0M | $198.0M | $68.00M | $63.00M | $55.00M | $51.00M | $51.00M | $10.00M | $9.000M | $8.000M | $10.00M | $9.000M | $6.000M | $2.000M | |
YoY Change | -2.89% | -3.32% | 0.89% | 8.57% | 29.06% | 21.58% | 15.01% | 25.88% | 35.96% | 43.57% | 6.0% | 42.12% | 10.41% | 0.14% | 32.33% | 18.08% | 24.1% | 48.56% | 8.97% | 12.63% | 191.18% | 7.94% | 14.55% | 7.84% | 0.0% | 410.0% | 11.11% | 12.5% | -20.0% | 11.11% | 50.0% | 200.0% | ||
Goodwill | ||||||||||||||||||||||||||||||||||
YoY Change | ||||||||||||||||||||||||||||||||||
Intangibles | ||||||||||||||||||||||||||||||||||
YoY Change | ||||||||||||||||||||||||||||||||||
Long-Term Investments | $1.163B | $1.245B | $1.309B | $502.0M | $1.488B | $1.423B | $11.19B | $20.50B | $11.60B | $1.598B | $439.0M | $720.0M | $64.00M | $3.219B | $2.248B | $1.450B | $1.550B | $453.0M | $2.000M | |||||||||||||||
YoY Change | -6.59% | -4.89% | 160.76% | -66.26% | 4.57% | -87.29% | -45.38% | 76.67% | 625.97% | 264.01% | -39.03% | 1025.0% | -98.01% | 43.19% | 55.03% | -6.45% | 242.16% | 22550.0% | ||||||||||||||||
Other Assets | $5.586B | $5.261B | $4.421B | $5.062B | $6.770B | $2.555B | $2.712B | $3.886B | $1.658B | $1.433B | $908.0M | $466.0M | $479.0M | $538.0M | $413.0M | $557.0M | $808.0M | $843.0M | $430.0M | $83.00M | $91.00M | $37.00M | $24.00M | $29.00M | $13.00M | $20.00M | $1.000M | $1.000M | $1.000M | $1.000M | $1.000M | $0.00 | $0.00 | |
YoY Change | 6.18% | 19.0% | -12.66% | -25.23% | 164.97% | -5.79% | -30.21% | 134.38% | 15.7% | 57.82% | 94.85% | -2.71% | -10.97% | 30.27% | -25.85% | -31.06% | -4.15% | 96.05% | 418.07% | -8.79% | 145.95% | 54.17% | -17.24% | 123.08% | -35.0% | 1900.0% | 0.0% | 0.0% | 0.0% | 0.0% | ||||
Total Long-Term Assets | $45.67B | $47.94B | $53.18B | $52.41B | $31.33B | $27.84B | $38.46B | $37.39B | $26.95B | $16.95B | $15.58B | $15.08B | $3.384B | $5.885B | $4.886B | $2.659B | $2.807B | $1.657B | $674.0M | $306.0M | $289.0M | $104.0M | $87.00M | $84.00M | $65.00M | $71.00M | $12.00M | $11.00M | $10.00M | $11.00M | $10.00M | $7.000M | $3.000M | |
YoY Change | -4.74% | -9.85% | 1.47% | 67.28% | 12.54% | -27.62% | 2.86% | 38.71% | 59.02% | 8.78% | 3.3% | 345.74% | -42.5% | 20.45% | 83.75% | -5.27% | 69.4% | 145.85% | 120.26% | 5.88% | 177.88% | 19.54% | 3.57% | 29.23% | -8.45% | 491.67% | 9.09% | 10.0% | -9.09% | 10.0% | 42.86% | 133.33% | ||
Total Assets | $62.13B | $63.17B | $67.95B | $68.41B | $61.63B | $63.68B | $70.28B | $56.98B | $51.72B | $34.66B | $22.58B | $21.24B | $17.30B | $11.59B | $9.699B | $6.937B | $5.835B | $4.086B | $3.766B | $2.156B | $1.555B | $1.288B | $795.0M | $678.0M | $437.0M | $488.0M | $352.0M | $311.0M | $167.0M | $102.0M | $127.0M | $147.0M | $109.0M | |
YoY Change | ||||||||||||||||||||||||||||||||||
Accounts Payable | $550.0M | $905.0M | $705.0M | $844.0M | $713.0M | $790.0M | $814.0M | $1.206B | $1.178B | $955.0M | $1.256B | $1.327B | $1.206B | $803.0M | $811.0M | $601.0M | $290.0M | $367.0M | $71.00M | $48.00M | $36.00M | $24.00M | $19.00M | $12.00M | $9.000M | $8.000M | $3.000M | $3.000M | $2.000M | $1.000M | $1.000M | $1.000M | $0.00 | |
YoY Change | -39.23% | 28.37% | -16.47% | 18.37% | -9.75% | -2.95% | -32.5% | 2.38% | 23.35% | -23.96% | -5.35% | 10.03% | 50.19% | -0.99% | 34.94% | 107.24% | -20.98% | 416.9% | 47.92% | 33.33% | 50.0% | 26.32% | 58.33% | 33.33% | 12.5% | 166.67% | 0.0% | 50.0% | 100.0% | 0.0% | 0.0% | |||
Accrued Expenses | $7.724B | $7.100B | $7.600B | $7.198B | $6.254B | $6.876B | $7.271B | $7.775B | $7.257B | $4.084B | $2.246B | $1.570B | $1.187B | $911.0M | $765.0M | $526.0M | $415.0M | $334.0M | $220.0M | $177.0M | $145.0M | $73.00M | $55.00M | $39.00M | $30.00M | $42.00M | $19.00M | $9.000M | $6.000M | $6.000M | $6.000M | $4.000M | $1.000M | |
YoY Change | 8.79% | -6.58% | 5.58% | 15.09% | -9.05% | -5.43% | -6.48% | 7.14% | 77.69% | 81.83% | 43.06% | 32.27% | 30.3% | 19.08% | 45.44% | 26.75% | 24.25% | 51.82% | 24.29% | 22.07% | 98.63% | 32.73% | 41.03% | 30.0% | -28.57% | 121.05% | 111.11% | 50.0% | 0.0% | 0.0% | 50.0% | 300.0% | ||
Deferred Revenue | ||||||||||||||||||||||||||||||||||
YoY Change | ||||||||||||||||||||||||||||||||||
Short-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
YoY Change | ||||||||||||||||||||||||||||||||||
Long-Term Debt Due | $1.798B | $2.273B | $1.516B | $2.757B | $2.499B | $2.748B | $2.747B | $0.00 | $982.0M | $483.0M | $2.697B | $1.169B | $2.000M | $646.0M | $6.000M | $6.000M | $0.00 | $19.00M | $60.00M | $0.00 | $0.00 | $0.00 | $1.000M | $3.000M | $3.000M | $5.000M | $2.000M | $4.000M | $3.000M | $3.000M | $1.000M | $1.000M | $0.00 | |
YoY Change | -20.9% | 49.93% | -45.01% | 10.32% | -9.06% | 0.04% | -100.0% | 103.31% | -82.09% | 130.71% | 58350.0% | -99.69% | 10666.67% | 0.0% | -100.0% | -68.33% | -100.0% | -66.67% | 0.0% | -40.0% | 150.0% | -50.0% | 33.33% | 0.0% | 200.0% | 0.0% | ||||||||
Total Short-Term Liabilities | $11.28B | $11.24B | $11.61B | $11.40B | $9.759B | $10.61B | $11.64B | $9.218B | $9.890B | $5.761B | $6.407B | $4.238B | $2.515B | $2.465B | $1.872B | $1.221B | $736.0M | $764.0M | $465.0M | $253.0M | $186.0M | $105.0M | $80.00M | $58.00M | $48.00M | $57.00M | $33.00M | $16.00M | $12.00M | $11.00M | $9.000M | $6.000M | $2.000M | |
YoY Change | 0.38% | -3.21% | 1.87% | 16.78% | -7.98% | -8.85% | 26.22% | -6.79% | 71.67% | -10.08% | 51.18% | 68.51% | 2.03% | 31.68% | 53.32% | 65.9% | -3.66% | 64.3% | 83.79% | 36.02% | 77.14% | 31.25% | 37.93% | 20.83% | -15.79% | 72.73% | 106.25% | 33.33% | 9.09% | 22.22% | 50.0% | 200.0% | ||
Long-Term Debt | $23.19B | $22.96B | $25.18B | $28.65B | $22.09B | $24.57B | $30.80B | $26.35B | $21.08B | $11.94B | $4.003B | $7.062B | $7.606B | $2.839B | $1.155B | $1.098B | $1.300B | $1.300B | $0.00 | $0.00 | $345.0M | $595.0M | $250.0M | $252.0M | $85.00M | $89.00M | $1.000M | $3.000M | $3.000M | $5.000M | $2.000M | $1.000M | $1.000M | |
YoY Change | 1.01% | -8.82% | -12.1% | 29.65% | -10.09% | -20.2% | 16.89% | 25.01% | 76.57% | 198.18% | -43.32% | -7.15% | 167.91% | 145.8% | 5.19% | -15.54% | 0.0% | -100.0% | -42.02% | 138.0% | -0.79% | 196.47% | -4.49% | 8800.0% | -66.67% | 0.0% | -40.0% | 150.0% | 100.0% | 0.0% | ||||
Other Long-Term Liabilities | $28.10B | $30.73B | $5.743B | $10.14B | $7.124B | $6.962B | $7.352B | $2.050B | $1.638B | $1.097B | $341.0M | $386.0M | $315.0M | $167.0M | $166.0M | $152.0M | $198.0M | $153.0M | $273.0M | $31.00M | $21.00M | $17.00M | $12.00M | $16.00M | $7.000M | $8.000M | ||||||||
YoY Change | -8.56% | 435.0% | -43.39% | 42.39% | 2.33% | -5.3% | 258.63% | 25.15% | 49.32% | 221.7% | -11.66% | 22.54% | 88.62% | 0.6% | 9.21% | -23.23% | 29.41% | -43.96% | 780.65% | 47.62% | 23.53% | 41.67% | -25.0% | 128.57% | -12.5% | |||||||||
Total Long-Term Liabilities | $28.10B | $30.73B | $30.92B | $38.79B | $29.22B | $31.54B | $38.15B | $28.40B | $22.71B | $13.03B | $4.344B | $7.448B | $7.921B | $3.006B | $1.321B | $1.250B | $1.498B | $1.453B | $273.0M | $31.00M | $366.0M | $612.0M | $262.0M | $268.0M | $92.00M | $97.00M | $1.000M | $3.000M | $3.000M | $5.000M | $2.000M | $1.000M | $1.000M | |
YoY Change | -8.56% | -0.64% | -20.28% | 32.76% | -7.35% | -17.33% | 34.34% | 25.02% | 74.27% | 200.02% | -41.68% | -5.97% | 163.51% | 127.55% | 5.68% | -16.56% | 3.1% | 432.23% | 780.65% | -91.53% | -40.2% | 133.59% | -2.24% | 191.3% | -5.15% | 9600.0% | -66.67% | 0.0% | -40.0% | 150.0% | 100.0% | 0.0% | ||
Total Liabilities | $39.38B | $41.96B | $46.88B | $50.21B | $39.10B | $42.29B | $49.84B | $38.09B | $33.18B | $19.24B | $11.21B | $11.94B | $10.56B | $5.729B | $3.331B | $2.664B | $2.375B | $2.270B | $739.0M | $285.0M | $552.0M | $717.0M | $342.0M | $327.0M | $140.0M | $154.0M | $35.00M | $19.00M | $15.00M | $16.00M | $11.00M | $7.000M | $3.000M | |
YoY Change | -6.16% | -10.5% | -6.62% | 28.39% | -7.53% | -15.15% | 30.85% | 14.79% | 72.48% | 71.63% | -6.1% | 13.0% | 84.4% | 71.99% | 25.04% | 12.17% | 4.63% | 207.17% | 159.3% | -48.37% | -23.01% | 109.65% | 4.59% | 133.57% | -9.09% | 340.0% | 84.21% | 26.67% | -6.25% | 45.45% | 57.14% | 133.33% |
Ownership
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares
Stock Issuance & Repurchase
Ownership Data
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Basic Shares Outstanding | 1.248B shares | 1.255B shares | 1.256B shares | 1.257B shares | 1.270B shares | 1.298B shares | 1.307B shares | 1.339B shares | 1.464B shares | 1.522B shares | 1.529B shares | 1.515B shares | 1.550B shares | 1.712B shares | ||||||||||||||||||||
Diluted Shares Outstanding | 1.258B shares | 1.262B shares | 1.262B shares | 1.263B shares | 1.277B shares | 1.308B shares | 1.319B shares | 1.358B shares | 1.521B shares | 1.647B shares | 1.695B shares | 1.583B shares | 1.580B shares | 1.747B shares | ||||||||||||||||||||
Preferred Stock | ||||||||||||||||||||||||||||||||||
Treasury Stock Shares |
Return On Shareholders' Equity
Book Value
Free Cash Flow
Free Cash Flow YoY
Free Cash Flow Margin
Dividends
Dividends
Stock Price
About GILEAD SCIENCES, INC.
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The company is headquartered in Foster City, California and currently employs 18,000 full-time employees. The company is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. The company is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada, Truvada for PrEP, Tybost, Veklury, Vemlidy, Viread, Vosevi, Yescarta and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, and Domvanalimab and zimberelimab, and seladelpar. Seladelpar shall be used for the treatment of primary biliary cholangitis (PBC), including pruritus. The firm operates in more than 35 countries.
Industry: Biological Products, (No Diagnostic Substances) Peers: AbbVie Inc. AMGEN INC BIOGEN INC. Moderna, Inc. REGENERON PHARMACEUTICALS, INC. VERTEX PHARMACEUTICALS INC / MA